Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study
International Journal of Neuropsychopharmacology · 2024
DOI: 10.1093/ijnp/pyae029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Berta Escudero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de investigación Sanitaria Hospital Universitario 12 de Octubre (imas12), Madrid, Spain. Hauptthemen laut MEDLINE: Apolipoproteins M, Cognitive Dysfunction, Inflammation, Alcoholism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Alcohol use disorder (AUD) courses with inflammation and cognitive decline. Apolipoproteins have emerged as novel target compounds related to inflammatory processes and cognition.
Methods
A cross-sectional study was performed on abstinent AUD patients with at least 1 month of abstinence (n = 33; 72.7% men) and healthy controls (n = 34; 47.1% men). A battery of plasma apolipoproteins (APOAI, APOAII, APOB, APOCII, APOE, APOJ, and APOM), plasma inflammatory markers (LPS, LBP), and their influence on cognition and presence of the disorder were investigated.
Results
Higher levels of plasma APOAI, APOB, APOE, and APOJ, as well as the proinflammatory LPS, were observed in the AUD group, irrespective of sex, whereas APOM levels were lower vs controls. Hierarchical logistic regression analyses, adjusting for covariates (age, sex, education), associated APOM with the absence of cognitive impairment in AUD and identified APOAI and APOM as strong predictors of the presence or absence of the disorder, respectively. APOAI and APOM did not correlate with alcohol abuse variables or liver status markers, but they showed an opposite profile in their associations with LPS (positive for APOAI; negative for APOM) and cognition (negative for APOAI; positive for APOM) in the entire sample.
Conclusions
The HDL constituents APOAI and APOM were differentially regulated in the plasma of AUD patients compared with controls, playing divergent roles in the disorder identification and associations with inflammation and cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de investigación Sanitaria Hospital Universitario 12 de Octubre (imas12), Madrid, Spain.
- Department of Psychobiology and Behavioral Sciences Methods, Faculty of Psychology, Complutense University of Madrid, Pozuelo de Alarcón, Spain.
- Riapad: Research Network in Primary Care in Addictions, Spain.
ORCID-Profile: Laura Orio
Zitieren
APA
Escudero, B., López-Valencia, L., Arias Horcajadas, F., & Orio, L. (2024). Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae029
Vancouver
Escudero B, López-Valencia L, Arias Horcajadas F, Orio L. Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyae029
BibTeX
@article{Escudero2024,
author = {Escudero, Berta and López-Valencia, Leticia and Arias Horcajadas, Francisco and Orio, Laura},
title = {Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study},
journal = {International Journal of Neuropsychopharmacology},
year = {2024},
doi = {10.1093/ijnp/pyae029}
}
EUVIMED